Skip to main navigation Skip to search Skip to main content

Immunothrombosis in hospitalized COVID-19 patients identified by multiomics profiling and linked to postacute complications

  • Laura Ansone*
  • , Līva Pelcmane
  • , Monta Brīvība
  • , Rihards Saksis
  • , Ivars Silamiķelis
  • , Kristaps Korņejevs
  • , Daniella Borisova
  • , Kaspars Megnis
  • , Līga Eliņa
  • , Vita Rovite
  • , Annija Vaska
  • , Kristaps Klavins
  • , Helgi B. Schiöth
  • , Janis Klovins*
  • *Corresponding author for this work
  • Latvian Institute of Organic Synthesis
  • Riga Technical University
  • Uppsala University

Research output: Contribution to journal › Article › peer-review

Abstract

Post-acute sequelae of COVID-19 (PASC) disproportionately affect hospitalized patients and require improved molecular characterization to inform patient management. Here, we performed a prospective longitudinal multi-omics study of hospitalized COVID-19 patients, analyzing whole blood transcriptomics, targeted urine metabolomics, kidney injury biomarkers, and electronic health record-based outcome stratification across acute illness, one-month, and three-month recovery time points. Interconnected immunothrombosis-related pathways dominated the acute phase, while most immune and metabolomic pathways partially normalize. However, patients who developed long COVID exhibited a distinct blood transcriptional signature at three months consistent with an endothelial-associated activation profile, including platelet reactivity, complement dysregulation, and low-grade vascular inflammation, distinguishing them from fully recovered individuals. This multi-omics approach identifies clinically measurable biomarkers associated with longitudinal molecular trajectories and supports post-acute risk stratification.

Original languageEnglish
Article number116326
Number of pages18
JournaliScience
Volume29
Issue number7
DOIs
Publication statusPublished - 17 Jul 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

OECD Field of Science

  • 3.2 Clinical Medicine

Keywords

  • Health sciences

Fingerprint

Dive into the research topics of 'Immunothrombosis in hospitalized COVID-19 patients identified by multiomics profiling and linked to postacute complications'. Together they form a unique fingerprint.

Cite this